The Effect of Viola flower Syrup on Cough of Children with Asthma: A Double-Blind Randomized Controlled Trial

How to cite

Gharehbeglou, Mohammad; Qasemzadeh, Mohammad Javad. 2014. "The Effect of Viola flower Syrup on Cough of Children with Asthma: A Double-Blind Randomized Controlled Trial." AEA RCT Registry. AEARCTR-0000580. https://doi.org/10.1257/rct.580-2.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Mohammad Gharehbeglou* , Mohammad Javad Qasemzadeh

* Primary investigator

Registry ID
AEARCTR-0000580
DOI
https://doi.org/10.1257/rct.580-2.0
First registered
Last updated
Status
Completed
Trial dates
2014-10-01 – 2014-12-17
Countries
Iran (Islamic Republic of) (Qom city)
Registry record
http://www.socialscienceregistry.org/trials/580

Abstract

This study is designed to evaluate violet flower syrup efficacy as add-on treatment in alleviation of cough in pediatric patients with intermittent asthma in a randomized double blind placebo-controlled clinical trial design. This study includes 182 children from out patient pediatric asthma clinic in Qom, Iran. Children between 2-12 years old with the clinical diagnosis of intermittent asthma are considered for inclusion in the study. Children who need or take treatments other than short acting beta agonists, having smoker family member, suffering from other chronic diseases will be excluded from the study. After taking the Informed consent from the parents the patients will be randomized to receive violet syrup with sulbutamol spray or placebo syrup with sulbutamol spray for 5 days. The patients will be evaluated regarding the duration lasted for the 50% cough alleviation and cough stop after 5 days. The numbers of patients achieve the cough alleviation and suppression before 3 days and 5 days will be compared between two groups.

Intervention

Active group: Salbutamol spray (2 puff- 216 mcg Q6h) + Violet syrup (2.5cc or 5cc three times per day for 2-5 and over 5 years old children, respectively)
Placebo group: Salbutamol spray (2 puff- 216 mcg Q6h) + Placebo syrup (2.5cc or 5cc three times per day for 2-5 and over 5 years old children, respectively)

Experimental design

The study will be done as Double-Blind Randomized Controlled Clinical Trial. The participants (182 children) will be randomly assigned, following block randomization with 1:1 allocation ration. Participants, their parents and those assessing the outcomes will be blinded to group assignment.

Design details

Randomization method
Block randomization, Generalized by Excel
Randomization unit
No clustered or more than one level randomization
Clusters
180 patient
Observations
180 patient
Arms
90 patient in intervention group and 90 patient in control group.
Primary outcomes
Number of patients achieved 100% cough suppression in 1-3 days in each group, based on parental report Number of patients achieved 100% cough suppression in 3-5 days in each group, based on parental report Number of patients not achieved 100% cough suppression in 5 days in each group, based on parental report Number of patients achieved 50% cough alleviation in 1-3 days in each group, based on parental report Number of patients achieved 50% cough alleviation in 3-5 days in each group, based on parental report Number of patients not achieved 50% cough alleviation in 5 days in each group, based on parental report

Cited by

No citation data available for this registration yet.

Keywords